Literature DB >> 22562669

Limitation of myocardial infarction by a structural analog of the peptide apelin-12.

O I Pisarenko1, Yu A Pelogeykina, Zh D Bespalova, L I Serebryakova, M V Sidorova, A A Az'muko, D N Khatri, I M Studneva, M E Pal'keeva, O V Tskitishvili, A S Molokoedov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22562669     DOI： 10.1134/S0012496612020044

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN： 0012-4966


× No keyword cloud information.
  9 in total

Review 1.  Emerging roles of apelin in biology and medicine.

Authors:  Matthias J Kleinz; Anthony P Davenport
Journal:  Pharmacol Ther       Date:  2005-08       Impact factor: 12.310

2.  Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury.

Authors:  James C Simpkin; Derek M Yellon; Sean M Davidson; Shiang Y Lim; Abigail M Wynne; Christopher C T Smith
Journal:  Basic Res Cardiol       Date:  2007-08-13       Impact factor: 17.165

Review 3.  Effect of apelin-apelin receptor system in postischaemic myocardial protection: a pharmacological postconditioning tool?

Authors:  Raffaella Rastaldo; Sandra Cappello; Anna Folino; Gianni Losano
Journal:  Antioxid Redox Signal       Date:  2010-11-30       Impact factor: 8.401

4.  Apelin-13 limits infarct size and improves cardiac postischemic mechanical recovery only if given after ischemia.

Authors:  Raffaella Rastaldo; Sandra Cappello; Anna Folino; Giovanni N Berta; Andrea E Sprio; Gianni Losano; Michele Samaja; Pasquale Pagliaro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-04       Impact factor: 4.733

5.  [Effects of exogenous apelin-12 on functional and metabolic recovery of isolated rat heart after ischemia].

Authors:  O I Pisarenko; V S Shulzhenko; Iu A Pelogeĭkina; I M Studneva; D N Kkhatri; Zh D Bespalova; A A Az'muko; M V Sidorova; M E Pal'keeva
Journal:  Kardiologiia       Date:  2010       Impact factor: 0.395

6.  Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase.

Authors:  Chad Vickers; Paul Hales; Virendar Kaushik; Larry Dick; James Gavin; Jin Tang; Kevin Godbout; Thomas Parsons; Elizabeth Baronas; Frank Hsieh; Susan Acton; Michael Patane; Andrew Nichols; Peter Tummino
Journal:  J Biol Chem       Date:  2002-01-28       Impact factor: 5.157

7.  Modification of the terminal residue of apelin-13 antagonizes its hypotensive action.

Authors:  Dennis K Lee; Victor R Saldivia; Tuan Nguyen; Regina Cheng; Susan R George; Brian F O'Dowd
Journal:  Endocrinology       Date:  2004-10-14       Impact factor: 4.736

8.  Temporal changes in myocardial salvage kinases during reperfusion following ischemia: studies involving the cardioprotective adipocytokine apelin.

Authors:  Christopher C T Smith; Michaela M Mocanu; Jonathan Bowen; Abigail M Wynne; James C Simpkin; Richard A Dixon; Michael B Cooper; Derek M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  2007-12       Impact factor: 3.727

9.  Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure.

Authors:  Said El Messari; Xavier Iturrioz; Celine Fassot; Nadia De Mota; Darren Roesch; Catherine Llorens-Cortes
Journal:  J Neurochem       Date:  2004-09       Impact factor: 5.372
  9 in total
  2 in total

1.  Elabela-apelin receptor signaling pathway is functional in mammalian systems.

Authors:  Zhi Wang; Daozhan Yu; Mengqiao Wang; Qilong Wang; Jennifer Kouznetsova; Rongze Yang; Kun Qian; Wenjun Wu; Alan Shuldiner; Carole Sztalryd; Minghui Zou; Wei Zheng; Da-Wei Gong
Journal:  Sci Rep       Date:  2015-02-02       Impact factor: 4.379

Review 2.  The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction.

Authors:  Alessandro Bellis; Ciro Mauro; Emanuele Barbato; Giuseppe Di Gioia; Daniela Sorriento; Bruno Trimarco; Carmine Morisco
Journal:  Cells       Date:  2020-09-21       Impact factor: 6.600
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.